Salarius Pharmaceuticals Inc - Asset Resilience Ratio

Latest as of March 2019: 78.89%

Salarius Pharmaceuticals Inc (SLRX) has an Asset Resilience Ratio of 78.89% as of March 2019. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Salarius Pharmaceuticals Inc to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$6.46 Million

Cash + Short-term Investments

Total Assets

$8.18 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2018)

This chart shows how Salarius Pharmaceuticals Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see SLRX asset base.

Liquid Assets Composition Over Time

This chart breaks down Salarius Pharmaceuticals Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore SLRX long-term investments to assets to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$6.46 Million	78.89%
Total Liquid Assets	$6.46 Million	78.89%

Asset Resilience Insights

Very High Liquidity: Salarius Pharmaceuticals Inc maintains exceptional liquid asset reserves at 78.89% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Salarius Pharmaceuticals Inc Industry Peers by Asset Resilience Ratio

Compare Salarius Pharmaceuticals Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
ALK-Abelló A/S CO:ALK-B	Biotechnology	0.98%
Mirum Pharmaceuticals Inc NASDAQ:MIRM	Biotechnology	6.89%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
BB Biotech AG SW:BION	Biotechnology	92.97%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Beijing Konruns Pharmaceutical Co Ltd SHG:603590	Biotechnology	10.55%

Annual Asset Resilience Ratio for Salarius Pharmaceuticals Inc (2015–2018)

The table below shows the annual Asset Resilience Ratio data for Salarius Pharmaceuticals Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2018-12-31	0.00%	$0.00	$10.39 Million	--
2017-12-31	40.38%	$14.13 Million	$34.99 Million	-20.78pp
2016-12-31	61.15%	$38.66 Million	$63.21 Million	+35.22pp
2015-12-31	25.93%	$24.65 Million	$95.07 Million	--

pp = percentage points

About Salarius Pharmaceuticals Inc

NASDAQ:SLRX USA Biotechnology

Market Cap

$4.81 Million

Market Cap Rank

#28761 Global

#5891 in USA

Share Price

$0.82

Change (1 day)

-2.40%

52-Week Range

$0.54 - $4.60

All Time High

$65800.00